Skip to content
Clinical Trials – home

Follicular lymphoma stage II Diagnostics

1 / 2 trials open to patients5 countries

In short

Diagnosing follicular lymphoma stage II involves a series of tests to confirm the presence of cancer, determine how far it has spread, and guide treatment decisions. Understanding these diagnostic procedures can help patients feel more prepared and informed about their journey ahead.

Key points

  • A tissue biopsy is the only definitive way to diagnose follicular lymphoma—no other test can replace it, making it an essential step despite any discomfort.
  • About 85% of follicular lymphoma cases involve a specific chromosome swap between chromosomes 14 and 18, transforming healthy immune cells into cancer cells.
  • Stage II follicular lymphoma has a five-year survival rate of about 90%, reflecting how this slow-growing cancer responds well to treatment.
  • Many people discover they have follicular lymphoma by accident during tests for other conditions because the disease often causes no symptoms early on.
  • PET-CT scans can reveal lymphoma throughout your entire body at once, even in places that can't be felt during a physical exam.
  • The grade of your lymphoma (how cells look under a microscope) is just as important as the stage (where it's located) for planning treatment.
  • Bone marrow biopsy samples are typically taken from your hip bone, not your spine, despite the procedure sometimes being confused with a spinal tap.
  • Clinical trials may require additional specialized tests beyond standard diagnostics, but participation is always voluntary and doesn't limit your other treatment options.

Introduction: Who Should Undergo Diagnostics

If you notice painless swelling in your neck, armpit, or groin, it's important to see your doctor. These swollen areas might be enlarged lymph nodes, which are small structures throughout your body that help fight infections. While not all swollen lymph nodes mean cancer, persistent swelling should be checked.

You should also seek medical attention if you experience symptoms like heavy sweating at night, high temperatures that come and go without obvious cause, feeling very tired, or losing a lot of weight without trying—especially if you lose more than one-tenth of your body weight. Doctors call fever, night sweats, and significant weight loss "B symptoms," and they are important to report.

Some people with follicular lymphoma don't have any symptoms at all. The disease can be discovered during routine check-ups or tests done for other reasons. This is why regular health screenings are valuable—they can catch conditions early, even before you feel unwell.

Follicular lymphoma most commonly affects adults over age 60, though it can occur in younger people too. If you have persistent symptoms or your doctor finds something unusual during an examination, diagnostic tests will be the next step to find out what's happening inside your body.

Classic Diagnostic Methods

Physical Examination

The diagnostic journey often begins with a physical exam. Your doctor will carefully check for swollen lymph nodes in your neck, underarms, and groin. They will also feel your abdomen to see if your spleen or liver is enlarged. This hands-on examination gives your doctor important clues about where the lymphoma might be located.

Lymph Node Biopsy

A biopsy is the only way to know for sure if you have follicular lymphoma. During this procedure, a doctor removes all or part of a swollen lymph node. The sample is then sent to a laboratory where specialists examine it under a microscope. This is called a lymph node biopsy.

There are different ways to perform a biopsy. Sometimes doctors remove an entire lymph node, which is called an excisional biopsy. Other times, they might take just a small piece using a needle. The type of biopsy depends on where the lymph node is located and how easy it is to reach. The tissue sample will show whether the cells are cancerous and what type of lymphoma is present.

Once follicular lymphoma is confirmed, specialists in the lab will look at how the cancer cells are arranged and count how many large abnormal cells are present. This helps them assign a grade to your lymphoma—grade 1, 2, 3A, or 3B. Grades 1, 2, and 3A are considered slow-growing, while grade 3B grows faster and may need different treatment.

Blood Tests

Blood tests are an important part of diagnosing follicular lymphoma. These tests help rule out infections or other conditions that might cause similar symptoms. They also check your overall health and how well your organs are working.

One specific blood test measures the level of lactate dehydrogenase (LDH), a substance that can be higher if the lymphoma is changing into a more aggressive type. Blood tests can also check your red blood cell count, white blood cell count, and platelet count. Low numbers might mean the lymphoma is affecting your bone marrow, where blood cells are made.

Bone Marrow Biopsy

To find out if cancer cells have spread to your bone marrow, you may need a bone marrow test. Bone marrow is the soft tissue inside your bones where blood cells develop. During this procedure, a doctor uses a needle to collect a small sample of bone marrow, usually from your hip bone.

There are actually two parts to this test: bone marrow aspiration draws out liquid marrow, and bone marrow biopsy removes a small piece of solid tissue. Both samples go to a lab for examination. Finding cancer cells in the bone marrow helps doctors understand the extent of the disease and plan treatment accordingly.

Imaging Tests

Imaging tests create pictures of the inside of your body, showing where lymphoma is located and how far it has spread. These tests are painless and non-invasive, meaning they don't require surgery or needles entering your body.

CT scans (computed tomography scans) use X-rays taken from different angles to create detailed cross-sectional images of your body. A CT scan can show enlarged lymph nodes in your chest, abdomen, or pelvis that can't be felt during a physical exam.

PET scans (positron emission tomography scans) use a small amount of radioactive sugar that cancer cells absorb more than normal cells. This makes the cancer light up on the scan, helping doctors see all the places where lymphoma is present. Often, PET and CT scans are done together (called a PET-CT scan) to give the most complete picture.

MRI scans (magnetic resonance imaging) use magnets and radio waves instead of radiation to create detailed images. MRI is especially helpful for looking at the brain, spinal cord, or soft tissues.

Cancer Staging

After all the tests are complete, your doctor will determine the stage of your follicular lymphoma. Staging describes how much of your body is affected by cancer and where it's located. Follicular lymphoma is staged from I to IV.

In Stage I, cancer is found in only one group of lymph nodes or in one area outside the lymph nodes. Stage II means cancer is in lymph nodes on the same side of your diaphragm—the muscle that separates your chest from your abdomen. Stage II specifically involves two or more groups of lymph nodes or nearby structures, but they're all either above or below the diaphragm.

Since follicular lymphoma often doesn't cause symptoms early on, many people are diagnosed at stage III or IV. However, even advanced stages can often be managed successfully with treatment. Your doctor will explain what your stage means for you and discuss the best treatment options.

Diagnostics for Clinical Trial Qualification

If you're considering joining a clinical trial, additional tests might be needed to see if you qualify. Clinical trials are research studies that test new treatments or new ways of using existing treatments. They follow strict rules about who can participate to ensure the study results are accurate and safe.

To enter a clinical trial for follicular lymphoma stage II, you'll typically need all the standard diagnostic tests we've already discussed: a confirmed biopsy showing follicular lymphoma, imaging tests like PET-CT scans to determine the stage, blood tests to check your overall health, and possibly a bone marrow biopsy.

Researchers running clinical trials need to know exactly what type and stage of lymphoma you have, what grade it is, whether you've had previous treatments, and how well your organs are functioning. This information helps them match you with the right study and ensures that the new treatment being tested is appropriate for your situation.

Some trials might require additional specialized tests that aren't part of routine diagnosis. For example, they might need extra tissue samples to study specific biomarkers—substances in your blood or tissue that give information about your cancer. These biomarkers can help predict how the cancer will behave or how well a treatment might work.

Your medical team will explain what tests are needed for any trial you're considering. Don't hesitate to ask questions about why each test is necessary and what the results might mean. Clinical trials can offer access to new treatments that aren't yet widely available, but it's important to understand what you're signing up for.

Prognosis and Survival Rate

Prognosis

The outlook for people with follicular lymphoma stage II is generally positive. Follicular lymphoma is a slow-growing cancer, and many people live for years after diagnosis. The disease can often be managed with treatment, and some people with early-stage disease, including stage II, may achieve long-term remission with radiation therapy alone. About half of people with stage I disease treated with radiation remain in remission for a long time.

Several factors affect how follicular lymphoma progresses. Age plays a role—people under 60 tend to have slightly better outcomes than those over 60. The grade of your lymphoma also matters. Lower grades (1, 2, and 3A) grow more slowly and are easier to manage, while grade 3B behaves more aggressively. Your overall health and how well your body responds to treatment are also important factors in your prognosis.

Although follicular lymphoma is not considered curable, it is treatable. The condition often responds well to therapy, and many people experience periods of remission when the cancer is controlled. However, the lymphoma may return after treatment. If it does come back, most people can be treated again. New treatments, including immunotherapy drugs, are helping people live longer with follicular lymphoma than ever before.

Survival Rate

Survival rates for follicular lymphoma stage II are encouraging. For stage II specifically, the five-year survival rate is about 90 percent, meaning that 9 out of 10 people are still alive five years after diagnosis.

Looking at follicular lymphoma overall, the five-year survival rate is approximately 90 percent across all stages. Many people live even longer—between 76 and 83 percent of people with follicular lymphoma are still living 10 years after diagnosis. These numbers reflect how slow-growing the disease is and how effective treatments have become.

It's important to remember that survival statistics are based on large groups of people and represent averages. Your individual outcome depends on many factors unique to you, including your age, the specific characteristics of your lymphoma, how it responds to treatment, and your overall health. Many people with follicular lymphoma die with the disease, not from it, meaning they live for years managing the condition and eventually pass away from other causes.

Did you know?

  1. Follicular lymphoma is named after the way cancer cells cluster together in clumps called "follicles" inside lymph nodes—this pattern is visible only under a microscope during biopsy examination.
  2. About 85% of follicular lymphoma cases involve a specific chromosome change where pieces of chromosomes 14 and 18 swap places, transforming normal infection-fighting B cells into cancer cells.
  3. Some people discover they have follicular lymphoma completely by accident during medical tests for unrelated health issues, since the disease often causes no symptoms in its early stages.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Follicular lymphoma stage II

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BGB-16673
  • Sponsor:BeOne Medicines AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Celgene Corp.
See all 2 trials →filters applied: condition = Follicular lymphoma stage II

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).